IPOGrid
0000811222
IPO filing research
Cardiff Lexington Corp
Services-Offices & Clinics of Doctors of Medicine · CDIX
follow-on
filed
OTCQX
S-1
Cardiff Lexington Corp IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1 on 2026-06-11. Current deal snapshot: exchange OTCQX.
Filing Timeline
SEC EDGAR
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
50,166,667 shares · Gross proceeds $75,000,000
Exchange OTCQX · Ticker CDIX · Selling stockholders only · Use of proceeds Up to $75 million in aggregate gross proceeds · Underwriters Leonite Fund I, LP
Cardiff Lexington Corp's S-1 filing outlines the terms of its IPO, including conditions for the Commencement Date, termination rights, and registration rights. Key elements include compliance with SEC regulations, restrictions on similar transactions, and a repurchase obligation if an Equity Transaction occurs. The filing also details the Purchase Agreement with a Selling Stockholder, including conditions for share purchases and termination triggers.
2026-06-11 · 0001683168-26-004763
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
First tracked pre-IPO filing for this issuer.
Cardiff Lexington Corporation has requested the withdrawal of its previously effective Registration Statement on Form S-1 (File No. 333-292145) for a proposed public offering. The company confirmed no securities were issued or sold under the registration, citing no intention to proceed with the offering. The withdrawal aligns with public interest and investor protection requirements under Rule 477.
2026-04-30 · 0001683168-26-003354
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
Cardiff Lexington Corp's Form S-1 filing became effective on February 13, 2026, marking the completion of its IPO registration process. The filing includes detailed disclosures about preferred stock series, common stock, and financial metrics, but no narrative updates or amendments are explicitly described in the provided text.
2026-02-13 · 9999999995-26-000571
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Cardiff Lexington Corporation's S-1/A filing updates its registration statement for an IPO, focusing on securities offerings and corporate governance details. The filing includes amendments to stock classifications, financial disclosures, and legal agreements, with a emphasis on preferred stock series, convertible notes, and executive leadership.
2026-02-05 · 0001683168-26-000787
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Class A · Includes representative's warrant and multiple common stock purchase warrants issued to entities like L&H, Inc. and Greentree Financial Group, Inc.
Cardiff Lexington Corporation's S-1/A filing represents an amendment to its initial registration statement, focusing on updating exhibits and corporate documentation. The filing includes key legal and financial agreements, such as underwriting agreements, loan documents, and preferred stock designations, indicating preparation for a securities offering. The company, based in Nevada, has undergone multiple corporate governance updates, including amendments to its articles of incorporation and preferred stock classifications.
2026-01-26 · 0001683168-26-000525
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Preferred Stock · Ticker CDIX
Cardiff Lexington Corp's S-1/A filing updates its financial disclosures and stock structure details compared to the previous S-1. The filing includes revised data on preferred stock series, common stock, additional paid-in capital, and retained earnings across multiple periods. Key updates involve adjustments to convertible preferred stock classifications and notes payable details, reflecting ongoing financial restructuring.
2026-01-20 · 0001683168-26-000426
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows RW in the pre-IPO sequence.
Ticker CDIX
Cardiff Lexington Corporation has filed a new S-1 registration statement following the withdrawal of its previous registration. The filing includes detailed financial data related to preferred stock series, common stock, and retained earnings, but lacks traditional narrative sections like business description or risk factors.
2025-12-15 · 0001683168-25-009164
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows S-1/A and ends the active registration process.
Cardiff Lexington Corporation has submitted a withdrawal request for its previously filed Registration Statement on Form S-1 (File No. 333-273324), citing Rule 477 under the Securities Act of 1933. The registration was never declared effective, and no securities were sold. The company seeks credit for fees paid to the SEC and confirms the withdrawal aligns with investor protection and public interest.
2025-05-02 · 0001683168-25-003049
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Cardiff Lexington Corp's S-1/A filing represents an amendment to its initial registration statement, focusing on adding exhibits and addressing SEC comments. The filing includes updated legal documents such as underwriting agreements, corporate governance filings, and various contractual agreements, reflecting ongoing preparation for its IPO. The company remains a holding company reliant on subsidiary distributions, with a focus on acquisition-driven growth.
2024-06-18 · 0001683168-24-004287
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
Exchange OTC · Ticker CDIX
Cardiff Lexington Corp's current FWP filing outlines an IPO offering of $8 million in common stock at a price range of $4.00-$6.00, with the company focusing on its healthcare division following the 2021 acquisition of Nova Ortho and Spine. The filing highlights the company's strategic shift from diversified operations to a specialized orthopedic healthcare model, emphasizing growth opportunities in the aging population and increasing healthcare demand. The offering includes underwriters Craft Capital Management LLC and R.F. Lafferty & Co., Inc.
2024-06-17 · 0001683168-24-004255
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Preferred
Cardiff Lexington Corp's S-1/A filing reflects updates in response to SEC comments, focusing on capital structure details, convertible notes, and preferred stock classifications. The company addresses financial disclosures, including liabilities, ownership transitions, and restatements, while highlighting its operational and legal developments.
2024-06-12 · 0001683168-24-004135
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Cardiff Lexington Corp's S-1/A filing represents an amendment to its initial IPO registration, likely addressing SEC comments. The document includes updated financial disclosures, with detailed classifications of preferred stock series, convertible notes, and liabilities. Key elements include restatements, changes in stockholder equity, and disclosures related to previous owners and settlements.
2024-05-31 · 0001683168-24-003912
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Cardiff Lexington Corp's S-1/A filing reflects updates to its capital structure, including preferred stock series (Series N, R, X, I, J, L) and convertible notes payable. The company disclosed financial data through 2024-03-31, with adjustments related to restatements and ownership transitions. Key focus areas include senior convertible preferred stock, convertible debt instruments, and corporate governance disclosures.
2024-05-14 · 0001683168-24-003418
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
Cardiff Lexington Corp's S-1/A filing reflects amendments to its initial registration statement, focusing on updates to preferred stock structures, convertible notes, and restatements of financial data. The filing includes detailed disclosures about various preferred stock series, convertible debt instruments, and adjustments to equity accounts, indicating ongoing refinements to the company's capital structure ahead of its IPO.
2024-04-05 · 0001683168-24-002132
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Senior Convertible Preferred Stock
Cardiff Lexington Corp filed an S-1/A amendment to its initial registration statement on August 3, 2023, updating disclosures related to its capital structure, including preferred stock series, convertible notes, and financial instruments. The filing includes updated financial data and corporate governance details, with no visible narrative changes beyond technical amendments.
2023-08-03 · 0001683168-23-005255
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows S-1/A in the pre-IPO sequence.
Cardiff Lexington Corp's S-1 filing outlines its securities registration, including preferred stock series, common stock offerings, and financial segment disclosures. The filing references prior amendments (S-1/A) and includes technical financial data, but lacks detailed narrative about business operations, risks, or strategic changes. The company's structure involves multiple preferred stock classes and potential conversions, with a focus on regulatory compliance and offering details.
2023-07-19 · 0001683168-23-004994
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $0.00 · 367,845,132 shares
Common · Exchange OTC Markets · Ticker CDIX · Selling stockholders only · Use of proceeds The company will not receive proceeds from this offering. · Underwriters GHS Investments LLC
Cardiff Lexington Corp. is a public holding company focused on acquiring niche businesses and commercial real estate. The S-1/A filing details an offering of 367,845,132 shares of common stock, with GHS Investments LLC as the selling stockholder. The company does not receive proceeds from the common stock sale but benefits from Series R Preferred stock sales. The offering is highly speculative, with limited trading volume and no guarantee of an active market.
2020-04-30 · 0001683168-20-001351
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
Price $0.00 · 438,000,000 shares
Common · Exchange OTC Markets · Ticker CDIX · Selling stockholders only · Use of proceeds Proceeds from Series R Preferred shares sold to GHS · Underwriters GHS Investments LLC
Cardiff Lexington Corp. is registering 438 million shares of common stock through a selling stockholder, GHS Investments LLC, under a securities purchase agreement. The offering involves shares convertible from Series R Preferred Stock and aims to provide liquidity to the selling stockholder. The company, a holding company, focuses on acquiring niche businesses and commercial real estate, with no proceeds directly received from the common stock sale but potential proceeds from preferred stock transactions. The offering is highly speculative with limited market history and no guaranteed trading liquidity.
2020-01-21 · 0001683168-20-000193
Comparable Deals
4 comparable deals
Healthcare & Biotech$50-100MLast 18 months
Only 0 strict matches; expanded to 4 using nearest neighbors.
Recent News
No recent news stored for this issuer.